查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466636

眼科市场：按疾病、产品类型、最终用户划分 - 全球预测 2024-2030

Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses & Lens), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年眼科市场规模为599亿美元，预计2024年将达638.9亿美元，复合年增长率为6.64%，2030年将达939.9亿美元。

眼科学包括对眼科疾病的诊断和治疗的药物和手术的研究。近年来，在白内障手术、屈光矫正手术和青光眼手术中观察到眼科领域的许多重要发展。设备齐全的医疗基础设施和药品核准的增加对市场做出了巨大贡献。另一方面，眼科疾病率的上升和全球人口意识的提高正在推动市场的成长。此外，由于技术进步导致眼保健设备价格上涨和眼保健成本上升可能会限制市场成长。眼科治疗方法领域的新兴研发活动得到巨额投资的支持，使得市场蓬勃发展。此外，持续的技术进步和人工智慧的整合用于眼科疾病的早期检测创造了利润丰厚的市场机会。

主要市场统计
基准年[2023] 599亿美元
预测年份 [2024] 638.9亿美元
预测年份 [2030] 939.9亿美元
复合年增长率（%） 6.64%

疾病：与老龄化的黄斑部病变疾病增加，导致中央视力进行性丧失

老龄化黄斑部病变(AMD) 是最常见的疾病，主要影响老年人并导致中央视力进行性丧失。此疾病分为干性（非新生血管）和湿性（新生血管）类型。干型的特征是黄斑区有玻璃膜疣堆积，而湿型则伴随新生血管，导致视力迅速丧失。危险因子包括年龄、遗传、吸烟和生活方式。抗 VEGF 治疗的最新进展显着改善了湿型AMD的治疗结果。白内障是一种眼睛水晶体变得混浊、视力下降的疾病。它通常与创伤、辐射暴露和某些遗传因素导致的衰老有关。症状包括视力模糊、看不清楚强光和颜色褪色。白内障的主要治疗方法是透过手术摘除浑浊的晶状体并用人工水晶体取代。科技的进步使白内障手术变得非常有效并提高了生活品质。

青光眼是一组损害视神经的眼科疾病，视神经对良好视力很重要，通常是由于异常高的眼压引起的。它是 60 岁以上人群失明的主要原因之一。有开放性青光眼和隅角闭锁性青光眼。透过定期眼科检查及早发现很重要，因为症状可能会在不知不觉中发展，直到出现严重的视力丧失。治疗选择包括眼药水、雷射治疗和手术以降低眼压并防止视神经进一步受损。眼部发炎疾病，例如葡萄膜炎、巩膜炎和眼部瘢痕性类天疱疮，涉及眼睛各部位的发炎。这些疾病可能是由自体免疫疾病、感染疾病或接触毒素引起的，如果不及时治疗，可能会导致视力丧失等严重併发症。症状包括发红、疼痛、视力模糊和对光敏感。治疗重点是根据根本原因和严重程度，使用皮质类固醇、免疫抑制剂和生物製药来减轻发炎。近视、远视、散光和老花眼等屈光不正是眼球形状阻止眼睛正确弯曲光线，导致视力模糊的疾病。这些是影响世界各地所有年龄层最常见的眼科疾病。现代矫正方法包括眼镜和隐形眼镜以及LASIK和 PRK 等先进外科手术。屈光矫正手术的技术发展不断提高安全性、有效性和病患满意度。

最终使用者：医院提供各种服务的贡献不断增加，从基本的眼科评估到复杂的手术干预

眼保健服务提供者包括多种营业单位，包括私人诊所、社区健康中心和专业视力保健提供者。这些营业单位处于实施创新眼保健服务的最前沿，从常规眼科检查到各种眼科疾病的高级诊断筛检和治疗方法。随着预防性护理和早期检测的兴起，医疗保健服务提供者越来越多地采用人工智慧等最尖端科技进行视网膜影像分析。

医院是眼科市场的重要组成部分，提供从基本眼科评估到复杂手术介入的各种服务。这些机构通常设有专门的眼科部门，配备最先进的设备来治疗急性和慢性眼科疾病。医院对于紧急管理、外科手术和需要多学科治疗的治疗至关重要。透过将先进的诊断和治疗技术与管理复杂病例的专业知识相结合，医院对于满足全面的眼科护理需求至关重要。专门从事眼科的医疗机构是推动创新和教育的核心。这些机构提供临床服务，并透过研究和发展为眼科知识的进步做出重大贡献。我们提供专门的培训和奖学金计划，帮助下一代眼科医生做好应对不断变化的眼科护理挑战的技能。医疗保健组织经常与产业合作伙伴合作进行临床试验并加速将研究成果转化为临床实践。以眼科为重点的研究机构致力于发现眼科疾病病理学的新见解，开发创新的诊断工具，并确定新的治疗策略。这些研究机构在提高我们对复杂眼科疾病的认识以及探索预防和治疗方法发挥着重要作用。这些组织经常与学术界、医疗保健提供者和产业的相关人员合作，推广多学科方法来解决眼部健康领域最紧迫的挑战。

区域洞察

世界各地（包括美国、加拿大、中国、印度、德国等）的眼科护理和诊断服务正在改善眼科护理设施的普及，并扩大知名製造商创新设备和治疗的可用性。由于年轻人生活方式的改变和忙碌的工作文化，智慧型手机、笔记型电脑、平板电脑和其他类似设备的使用增加，在新兴经济体和已开发经济体中，屈光不良的负担正在增加。此外，来自中国、印尼、日本和韩国等多个国家的製造商不断生产独特的眼镜，以补充亚太地区的人口，并显着塑造亚太地区的眼科市场空间。此外，随着医疗机构和成熟市场参与者的研究活动的迅速增加和巨大的技术进步，以及人工智慧等尖端技术的整合，用于治疗和矫正视力障碍的眼科产品将出现在各个领域。年的经济使用量预计会增加。

FPNV定位矩阵

FPNV定位矩阵对于评估眼科市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对眼科市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，以获得市场竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.眼科市场的市场规模和预测是多少？

2.眼科市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3.眼科市场的技术趋势和法规结构是什么？

4.眼科市场主要厂商的市场占有率是多少？

5.进入眼科市场的合适形式和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 眼科疾病率上升及公众意识增强
      • 处方眼镜和镜片的采用率增加
      • 拥有设备齐全的医疗基础设施和不断增加的药品核准数量
    • 抑制因素
      • 眼科治疗费用高
    • 机会
      • 眼科护理的新研究活动和津贴
      • 透过眼科技术整合可实现高可用性
    • 任务
      • 眼科手术专家数量有限
  • 市场区隔分析
    • 疾病：因老龄化黄斑部病变的进展而导致中心视力丧失
    • 最终使用者：医院提供从基本眼科检查到复杂手术介入等各种服务的贡献增加
  • 市场趋势分析
    • 远距远端医疗的出现和整个美洲眼保健的扩展
    • 新兴企业，由于亚太地区失明和视力障碍的普遍存在，眼科药物的需求不断增长。
    • 欧洲、中东和非洲眼科药物的研究活动迅速增加，技术不断进步
  • 俄罗斯和乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章眼科市场：依疾病分类

  • 老龄化黄斑部病变
  • 白内障
  • 青光眼
  • 发炎疾病
  • 屈光不正

第七章眼科市场：依产品类型

  • 药物
  • 装置
  • 处方眼镜和镜片
  • 软体

第八章眼科市场：依最终使用者分类

  • 医疗保健服务供应商
  • 医院
  • 医疗机构
  • 调查机构

第九章 北美和南美眼科市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太眼科市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲眼科市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • Alkeus 宣布获得 1.5 亿美元 B 轮资金筹措
    • HOYA Vision 推出 MiYOSMART 太阳镜片预防儿童近视
    • Curative Biotechnology 申请眼药水专利
    • Eyetelligence是一家基于人工智慧的眼科疾病检测Start-Ups，从投资者筹集了1200万美元
    • Eyenovia 宣布 FDA核准首款散瞳喷雾剂 Mydcombi，该喷雾剂也利用了该公司专有的 Optejet 设备平台
    • 安斯泰来同意以 59 亿美元收购 Iveric Bio
    • 博士伦 (Bausch + Lomb) 宣布在美国推出 StableVisc 黏性眼科黏性手术器械和 TotalVisc 黏弹系统
    • NIDEK推出非接触式眼压计NT-1/1e
    • 塞拉尼斯宣布与 Glaukos Corporation 就缓释青光眼治疗达成协议
    • Thea Open Innovation 和 Galimedix 宣布产品开发和商业化策略
    • Grifols 与 Selagine 签署协议，开发用于治疗干眼症的免疫球蛋白眼药水
    • Topcon Healthcare 与 OphtAI 宣布在欧洲、中东和非洲地区建立合作伙伴关係
    • Eyenovia 与 Formosa 合作开发新型眼科治疗药物
    • Viatris 收购 Oyster Point Pharma 和 Famy Life Sciences 成立眼科护理部门

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-4348D129FA96

[189 Pages Report] The Ophthalmology Market size was estimated at USD 59.90 billion in 2023 and expected to reach USD 63.89 billion in 2024, at a CAGR 6.64% to reach USD 93.99 billion by 2030.

Ophthalmology includes the study of medicines & surgeries dealing with the diagnosing and treating of eye disorders. Over the last few years, many significant developments in ophthalmology have been observed for cataract, refractive, and glaucoma surgeries. An increase in the well-equipped healthcare infrastructure and drug approvals strongly contribute to the market. Moreover, the rising prevalence of eye disorders and growing awareness among the worldwide population are driving the market growth. Furthermore, the high cost of ophthalmologic treatments due to the increasing prices of ophthalmologic treatment devices and technological advances may limit the market growth. Emerging research and development activities of ophthalmology treatments are supported by huge investments, prospering the market. Additionally, ongoing technological advancement and integration of artificial intelligence for early eye disease detection create lucrative market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 59.90 billion
Estimated Year [2024] USD 63.89 billion
Forecast Year [2030] USD 93.99 billion
CAGR (%) 6.64%

Diseases: proliferation of age-related macular degeneration disease resulting in progressive loss of central vision

Age-related macular degeneration (AMD) is the most occurring condition primarily affecting older adults, leading to a progressive loss of central vision. This condition is categorized into dry (non-neovascular) and wet (neovascular) forms. The dry form is characterized by the accumulation of drusen in the macula, while the wet form involves neovascularization, causing rapid vision loss. Risk factors include age, genetics, smoking, and lifestyle. Recent advancements in anti-VEGF therapy have significantly improved treatment outcomes for wet AMD. A cataract represents clouding of the eye's natural lens, resulting in decrease in vision quality. It is most commonly related to aging resulting from trauma, radiation exposure, and certain genetic factors. Symptoms include blurred vision, difficulty with bright lights, and faded colors. The most primary treatment for cataracts is surgical removal of the clouded lens and replaced by an artificial lens implant. With technological advances, cataract surgery has become highly effective and offers improved quality of life.

Glaucoma represents a group of eye conditions that damage the optic nerves, crucial for good vision, often due to abnormally high pressure in the eye. It is one of the main causes of blindness for people over the age of 60. Types include open-angle and angle-closure glaucoma. Early detection through regular eye exams is important as the condition can progress unnoticed until significant vision loss occurs. Treatment options include eye drops, laser treatment, & surgery to lower eye pressure, thus preventing further optic nerve damage. Inflammatory diseases of the eye including uveitis, scleritis, and ocular cicatricial pemphigoid, involve inflammation of various parts of the eye. These conditions can arise due to autoimmune disorders, infection, or exposure to toxins and can lead to severe complications if left untreated, including vision loss. Symptomatology includes redness, pain, blurred vision, and light sensitivity. Treatment focuses on controlling inflammation with corticosteroids, immunosuppressive agents, and biologics tailored according to the underlying cause and severity of the disease. Refractive disorders, including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, are conditions in which the shape of the eye enables it to bend light correctly, resulting in blurred vision. They are among the most common ocular conditions affecting people of all ages globally. Modern corrective measures range from eyeglasses and contact lenses to advanced surgical options, including LASIK and PRK. Developments in refractive surgery techniques continue to enhance safety, efficacy, and patient satisfaction.

End User: Increasing contribution of Hospitals providing various services ranging from basic ophthalmic evaluations to complex surgical interventions

Healthcare service providers in ophthalmology encompass a broad range of entities, including private clinics, community health centers, and specialized vision care providers. These entities are at the forefront of implementing innovative eye care services, from routine eye exams to advanced diagnostic screenings and treatment modalities for various eye conditions. With a growing preventive care and early detection, healthcare service providers are increasingly adopting cutting-edge technologies such as AI for retinal imaging analysis.

Hospitals constitute a significant segment of the ophthalmology market, providing various services ranging from basic ophthalmic evaluations to complex surgical interventions. These institutions often house specialized ophthalmology departments with state-of-the-art facilities to manage acute and chronic eye conditions. Hospitals are crucial in managing emergencies, surgical procedures, and treatments requiring multidisciplinary care. The integration of advanced diagnostic and therapeutic technologies, alongside expertise in managing complicated cases, renders hospitals indispensable in addressing comprehensive eye health needs. Medical institutes specializing in ophthalmology are central to driving innovation and education. These institutes provide clinical services and contribute significantly to the advancement of ophthalmic knowledge through research and development. They offer specialized training and fellowship programs, preparing the next generation of ophthalmologists with the skills to address evolving eye health challenges. Medical institutes often collaborate with industry partners to conduct clinical trials, facilitating the translation of research findings into clinical practice. Research organizations dedicated to ophthalmology focus on uncovering new insights into the pathophysiology of eye diseases, developing innovative diagnostic tools, and identifying novel therapeutic strategies. Their work is instrumental in broadening our understanding of complex eye conditions and in the quest for preventative measures and cures. These organizations often collaborate with academia, healthcare providers, and industry stakeholders, driving interdisciplinary approaches to tackle the most pressing challenges in eye health.

Regional Insights

The utilization of ophthalmology treatment and diagnostics worldwide, including in the U.S., Canada, China, India, Germany, and others, is evolving rapidly with improving accessibility to ophthalmology care facilities and the growing availability of innovative devices and treatments offered by prominent manufacturers. The increasing utilization of smartphones, laptops, tablets, and other similar devices with changing lifestyles and busy work cultures among the younger population has increased the burden of refractive disorders in developing and developed economies. Furthermore, manufacturers from several countries, including China, Indonesia, Japan, and South Korea, are consistently producing unique eyeglasses that complement the regional population, significantly shaping the ophthalmology market space in the Asia-Pacific region. Moreover, with surging research activities and tremendous technological advancements undertaken by medical institutes and well-established market players, and integration of advanced technologies such as artificial intelligence is expected to increase the use of ophthalmologic products to treat and correct vision impairment across economies in the coming years.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Ophthalmology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ophthalmology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch + Lomb Corporation, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight, CooperVision, Inc., Duopharma Consumer Healthcare Sdn Bhd, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd., Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., PharmOptima LLC, Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Topcon Corporation, Unimed Pharma, Spols r.o., and Visioncare Optolab Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Ophthalmology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diseases
    • Age-Related Macular Degeneration
    • Cataract
    • Glaucoma
    • Inflammatory Diseases
    • Refractive Disorders
  • Product Type
    • Drugs
      • Allergic Conjunctivitis & Inflammation Drugs
      • Dry Eye Drugs
      • Glaucoma Drugs
      • Retinal Disorder Drugs
    • Equipment
      • Diagnostic Devices
      • Surgical Devices
        • Intraocular Lenses
        • Ophthalmic Lasers
    • Prescription Glasses & Lens
    • Software
  • End User
    • Healthcare Service Providers
    • Hospitals
    • Medical Institutes
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Ophthalmology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ophthalmology Market?

3. What are the technology trends and regulatory frameworks in the Ophthalmology Market?

4. What is the market share of the leading vendors in the Ophthalmology Market?

5. Which modes and strategic moves are suitable for entering the Ophthalmology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and increasing number of drugs approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diseases: proliferation of age-related macular degeneration disease resulting in progressive loss of central vision
    • 5.2.2. End User: Increasing contribution of Hospitals providing various services ranging from basic ophthalmic evaluations to complex surgical interventions
  • 5.3. Market Trend Analysis
    • 5.3.1. Emergence of telehealth and expansion of ophthalmology care across Americas
    • 5.3.2. Start-ups focusing on developing ophthalmology drugs with increasing need due to prevalence of blindness & vision impairment in Asia-Pacific
    • 5.3.3. Surging research activities and continuous technological advancements in ophthalmology therapeutics in EMEA
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
  • 7.3. Equipment
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Alkeus Announces USD 150 million Series B Financing,
    • 12.3.2. HOYA Vision launches MiYOSMART Sun lenses to protect against myopia in children
    • 12.3.3. Curative Biotechnology files patent on ophthalmic formulation
    • 12.3.4. AI-based eye disease detection startup, Eyetelligence raises USD 12 million USD from investors
    • 12.3.5. Eyenovia Announces Fda Approval Of Mydcombi, The First Ophthalmic Spray For Mydriasis, Which Also Leverages The Company's Proprietary Optejet Device Platform
    • 12.3.6. Astellas reaches agreement to acquire Iveric Bio for USD 5.9 billion
    • 12.3.7. Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
    • 12.3.8. NIDEK launches the NT-1/1e Non Contact Tonometer
    • 12.3.9. Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
    • 12.3.10. Thea Open Innovation and Galimedix announce strategic to develop and commercialize products
    • 12.3.11. Grifols enters agreement with Selagine to develop immunoglobulin eye drops to treat dry eye disease
    • 12.3.12. Topcon Healthcare and OphtAI Announce their Partnership in EMEA
    • 12.3.13. Eyenovia and Formosa partner for new ophthalmic therapeutics
    • 12.3.14. Viatris Forms Eye Care Unit from Acquisitions of Oyster Point Pharma and Famy Life Sciences

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. OPHTHALMOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 355. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 356. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 362. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 363. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 364. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 365. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 366. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 367. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 368. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 372. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 373. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 374. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 375. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-20